Shanghai No. 1 Pharmacy Co. Ltd. (600833) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai No. 1 Pharmacy Co. Ltd.

Why is Shanghai No. 1 Pharmacy Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 6.55% and Operating profit at -18.96% over the last 5 years

The company declared very negative results in Mar'25 after negative results in Dec'24

NET PROFIT(HY) At CNY 48.53 MM has Grown at -56.39%
ROCE(HY) Lowest at 6.05%
OPERATING PROFIT(Q) Lowest at CNY -0.84 MM

With ROE of 4.34%, it has a very expensive valuation with a 2.80 Price to Book Value

Over the past year, while the stock has generated a return of 0.89%, its profits have fallen by -70.8%

Underperformed the market in the last 1 year

The stock has generated a return of 0.89% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai No. 1 Pharmacy Co. Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Shanghai No. 1 Pharmacy Co. Ltd.

-10.53%

0.56

31.78%

China Shanghai Composite

13.33%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.55%

EBIT Growth (5y)

-18.96%

EBIT to Interest (avg)

5.25

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.22

Sales to Capital Employed (avg)

1.57

Tax Ratio

24.25%

Dividend Payout Ratio

30.10%

Pledged Shares

Institutional Holding

ROCE (avg)

5.63%

ROE (avg)

10.06%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.80

EV to EBIT

167.61

EV to EBITDA

30.12

EV to Capital Employed

3.57

EV to Sales

1.37

PEG Ratio

Dividend Yield

1.59%

ROCE (Latest)

2.13%

ROE (Latest)

4.34%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -20.78% (YoY

PRE-TAX PROFIT(Q)

Highest at CNY 52.37 MM

NET PROFIT(Q)

Highest at CNY 39.25 MM

EPS(Q)

Highest at CNY 0.18

-12What is not working for the Company

NET PROFIT(HY)

At CNY 48.53 MM has Grown at -56.39%

ROCE(HY)

Lowest at 6.05%

OPERATING PROFIT(Q)

Lowest at CNY -0.84 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -0.16 %

Here's what is working for Shanghai No. 1 Pharmacy Co. Ltd.

Pre-Tax Profit

At CNY 52.37 MM has Grown at 124.02%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 39.25 MM has Grown at 123.8%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 52.37 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 39.25 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.18

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -20.78% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai No. 1 Pharmacy Co. Ltd.

Operating Profit

Lowest at CNY -0.84 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -0.16 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales